|
|
|
Press Release: 20th Anniversary Pharmaceutical and Medical Device Compliance Congress Features Annual CCO Roundtable
|
- Sponsored by the Pharmaceutical Compliance Forum
- November 6 - 8, 2019
- Onsite at the Mandarin Oriental, Washington, DC
- Online in Your Own Office or Home Live via the Internet with 24/7 Access for Six Months
- Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: registration@hcconferences.com
Website: www.PharmaCongress.com
|
EARLY BIRD REGISTRATION
- SAVE UP TO $400 -
|
Register by Friday, September 13, 2019
and save up to $400.
Click here to register.
|
|
|
FEATURING THE ANNUAL CHIEF COMPLIANCE OFFICER ROUNDTABLE WITH
|
Charlene E. Davis, JD
Associate Vice President and Head of Healthcare, Compliance North America, Sun Pharmaceutical Industries, Inc., Former Senior Compliance Counsel & Sr. Director, Corporate, Compliance & Compliance Operations, Otsuka Pharmaceutical, Princeton, NJ |
Adam Dubow, JD
Global Chief Compliance and Ethics Officer, Bristol-Myers Squibb, Princeton, NJ |
Keith Korenchuk, MPH, JD
Vice President and Chief Compliance Officer, Danaher Diagnostics, and Beckman Coulter Diagnostics, DANAHER Corporation, Former Partner, Arnold & Porter Kaye Scholer, Chevy Chase, MD
|
Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Compliance Officer, Ipsen Honorary President, International Society of Healthcare Ethics, and Compliance Professionals (ETHICS), Paris, France |
Sunitha Ramamurthy, JD
Head of Compliance, Loxo Oncology, wholly owned subsidiary of Eli Lilly, Former Executive Director, Office of Ethics and Compliance, Boehringer Ingelheim Pharmaceuticals; Stamford, CT
|
Caroline West, JD
Global Chief Compliance Officer, Olympus Corporation, Former Sr. VP, Chief Compliance and Risk Officer, Shire, Former VP Global Legal Compliance, Aventis, Philadelphia, PA |
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA (Moderator)
|
|
|
|
WASHINGTON, DC USA -- EMPLOYEE BENEFIT UPDATE NEWS SERVICE™ -- AUGUST 8, 2019: The 20th Anniversary Pharmaceutical and Medical Device Compliance Congress, www.PharmaCongress.com, will be held November 6 - 8, 2019 at the Mandarin Oriental in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).
|
FEATURING INVITATION-ONLY:
CHIEF COMPLIANCE OFFICER ROUNDTABLE
|
|
(Jointly Sponsored by PCF and PhRMA; Special 11/6 Morning Session, Invitation-only)
|
 |
|
|
FEATURING
|
Sally Molloy, JD
Acting Chief, Strategy, Policy & Training Unit, Fraud Section, Former Assistant U.S. Attorney, US Attorney's Office, Northern District of Georgia, US Department of Justice, Washington, DC
|
|
KEYNOTE SPEAKERS
|
Thomas W. Abrams, RPh, MBA
Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD |
Brian Allen Benczkowski, JD
Assistant Attorney General, Criminal Division, US Department of Justice, Principal Deputy Assistant Attorney General for Legislative Affairs Former Republican Staff Director, Committee on the Judiciary, US Senate Former Staff, Senator Pete Domenici and Representative Jim Sensenbrenner, Washington, DC
|
Alexandra Christina, Countess of Frederiksborg
Member, Board of Directors - Chairperson Ethics and Compliance Board Committee, Ferring Pharmaceuticals, Co-author, The Sincerity Edge, Former Poling Chair of Business and Government, Kelley School of Business, Indiana University, Copenhagen, Denmark |
Susan Dentzer
Visiting Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC
|
Robert I. Dodge, JD
Assistant Director, FCPA Unit, US Securities & Exchange Commission, Former Assistant U.S. Attorney, US Attorney's Office, Western District of Michigan, Former Assistant Section Chief, Environmental Defense Section, US Department of Justice, Washington, DC |
Daniel Ronald Levinson, JD
Former Inspector General, US Department of Health and Human Services, Former Inspector General, US General Services Administration, Former Chairman, US Merit Systems Protection Board, Former General Counsel, US Consumer Product Safety Commission, Washington, DC
|
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC |
James Sheehan, JD
Chief, Charities Bureau at Attorney General of New York, Former Chief Integrity Officer, Executive Deputy Commissioner, City of New York Human Resources Administration, Former NY Medicaid Inspector General, Former Associate United States Attorney, US Attorney's Office for the Eastern District of Pennsylvania, New York, NY
|
|
AND A FRIDAY, NOVEMBER 8 INDUSTRY-ONLY
BEST PRACTICES ROUNDTABLE
|
|
(Industry-only session for pharma and medical device compliance professionals and in-house counsel only)
|
|
FEATURING
|
Jacob T. Elberg, JD
Associate Professor of Law, Seton Hall Law School, Former Chief, Health Care & Government Fraud Unit and Assistant US Attorney, US Attorney's Office, District of New Jersey, US Department of Justice, Newark, NJ
|
|
|
FEATURED FACULTY
|
Meredith S. Auten, JD
Partner, Morgan Lewis, Co-chair, White Collar Committee Qui Tam Subcommittee, ABA Criminal Justice Section, Philadelphia, PA |
Yogesh Bahl, CPA, MBA
Managing Director, AlixPartners, New York, NY |
Ann E. Beasley, JD
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Former Senior Vice President, Chief Compliance Officer, Biogen, Boston, MA
|
Thomas Beimers, JD
Partner, Hogan Lovells, Former Senior Counsel, Office of Counsel to the Inspector General, Former Special Assistant United States Attorney, US Attorney's Office, Eastern District of Michigan, Minneapolis, MN and Washington, DC |
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC |
Ela Bochenek, JD
Vice President and Chief Compliance Officer, Nabriva Therapeutics PLC, Former Assistant Dean Graduate & Professional Education, Seton Hall University School of Law, King of Prussia, PA
|
Kathleen M. Boozang, JD, LLM
Dean and Professor of Law, Seton Hall University School of Law, Newark, NJ |
Bernadette M. Broccolo, JD
Partner, McDermott Will & Emery LLP, Chicago, IL |
Christie Camelio
Vice President, Deputy Global Chief Compliance Officer, Celgene, Former Executive Director, Head of Risk Management Center of Excellence, Novartis Pharmaceuticals, Florham Park, NJ
|
Jennifer Chillas, JD
Senior Corporate Counsel, Bristol-Myers Squibb, New York, NY |
Brian Conner
Chief Compliance Officer, Strongbridge Biopharma plc, Former Assistant Compliance Officer of the Americas, Shire, Feasterville Trevose, PA |
Thomas Costa, JD
Member, US Board of Directors, Sanofi, Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC
|
Tiffany Cummings-Damiani, MBA
Vice President, Corporate and Healthcare Compliance, Global Compliance, Insmed, Former Senior Director, Global Compliance, Teva, Philadelphia, PA |
Kris Curry, MBA
Principal, Assurance Services, EY, Former Vice President, Global Chief Compliance Officer, Pharma Sector, Johnson & Johnson, Philadelphia, PA |
Meenakshi Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin LLP, Chicago, IL
|
BJ D'Avella, MBA
Sr. Manager, Life Sciences Advisory, Deloitte & Touche LLP, New York, NY |
Charlene E. Davis, JD
Associate Vice President & Head of Healthcare Compliance North America, Sun Pharmaceutical Industries, Princeton, NJ |
CJ DeKreek, MBA
Senior Director, Ankura, Atlanta, GA
|
Julie DeLong, CFA
Senior Managing Director, Ankura Consulting Group, LLC, Atlanta, GA |
Gary Del Vecchio
Health Care Compliance Officer Cardiovascular & Metabolism and Puerto Rico, Janssen; Former Executive Director, US Pharmaceutical Compliance and Ethics, BMS, Pennington, NJ |
Sarah diFrancesca, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY
|
Christian A. Dingler
Associate Director, Navigant, Life Sciences, Richmond, VA |
Stefanie A. Doebler, JD
Of Counsel, Covington & Burling LLP, Washington, DC |
Adam Dubow, JD
Global Chief Compliance and Ethics Officer, Bristol-Myers Squibb, Princeton, NJ
|
Gildas Durand
Principal, Forensic & Integrity Services, EY, Miami, FL |
Eileen Erdos
Principal, Forensic & Integrity Services, Chicago, IL |
Margaret K. Feltz, MA, JD
Vice President, Ethics and Compliance, Purdue Pharma LP, Former Member, PCF Executive Committee, Stamford, CN
|
Alison Fethke, JD
Counsel, Ropes & Gray LLP, Former Division Counsel, Legal, Regulatory and Compliance, AbbVie, Chicago, IL |
Christine Fiore, MBA
Executive Director, Ethics and Commercial Compliance, Boehringer Ingelheim, Former Group Director Ethics and Compliance, Smith & Nephew, Ridgefield, CT |
Sarah A. Franklin, JD
Partner, and Vice-chair, Life Sciences Litigation and Investigations, Covington & Burling LLP, Former Attorney, Bureau of Consumer Protection, FTC, Washington, DC
|
Nereyda Garcia, JD
Global Head, Ethics and Compliance, Alnylam Pharmaceuticals, Cambridge, MA |
Deeona Gaskin, MPH, JD
Associate, Sidley Austin LLP, Former Associate Chief Council, FDA, Washington, DC |
Gary F. Giampetruzzi, JD
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY
|
Virginia "Ginny" A. Gibson, JD
Partner, Hogan Lovells LLP, Former First Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA |
Thomas M. Glavin, JD
Chief Compliance Officer for the Americas, Olympus Corporation of the Americas; Former Vice President, US/Americas Compliance Officer, Shire, Center Valley, PA |
Jonathan Glazier, MBA, JD
Head of Legal Compliance, Philips North America, Former Sr Director of Corporate Compliance and Privacy Officer, Fresenius Medical Care North America, Andover, MA
|
Kimberly J. Gold, JD, CIPP/US
Partner, Life Sciences Health Industry and Data Privacy Groups, Reed Smith, New York, NY |
Wendy C. Goldstein, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY |
Kimi Gorman, CCEP, CFE
Director, Ethics & Compliance, Novo Nordisk Inc., Former Compliance Manager, B. Braun Medical, Princeton, NJ
|
Adam Greene, JD, MPH
Partner and Co-chair, Health Information & HIPAA Practice, Davis Wright Tremaine LLP, Former Senior Health Information Technology and Privacy Specialist, Office for Civil Rights, HHS, Washington, DC |
Amy Greenstein, JD/MSFS
Associate Principal, IQVIA, Boston, MA |
Nancy Grygiel, JD
Vice President, Worldwide Compliance & Business Ethics, Amgen, Former Senior Director, Global Compliance, Mylan, Newbury Park, CA
|
Rachael A. Honig, JD
First Assistant U.S. Attorney, U.S. Attorney's Office, District of New Jersey, US Department of Justice; Former Corporate Counsel, Litigation, Celgene; Newark, NJ |
Casey J. Horton, CFE
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Chicago, IL |
William Hrubes, MS
Vice President and Chief Compliance Officer, ACell, Inc. Former Healthcare Compliance Officer, DePuy Orthopaedics, Columbia, MD
|
Darren R. Jones, CIA
Senior Principal, Commercial Compliance, Global Consulting Practice Leader, IQVIA, New York, NY |
Keith Korenchuk, MPH, JD
VP and Chief Compliance Officer Danaher Diagnostics and Beckman Coulter Diagnostics, DANAHER Corporation; Former Partner, Arnold & Porter Kaye Scholer; Chevy Chase, MD |
Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Compliance Officer, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
|
Puja Leekha, JD
Vice President, Chief Compliance Officer, and Corporate Counsel, Corporate Compliance, Lundbeck Pharmaceuticals LLC; Former Division Legal Counsel & Compliance Officer, Stryker Corporation; Deerfield, IL |
Richard Liner, JD, MPH
Senior Counsel, Compliance & Investigations, Bayer Healthcare, Whippany, NJ |
Mark Linver, MS
Managing Director, Deloitte & Touche LLP, Stamford, CT
|
Carrie Sarhangi Love, JD
Litigation Partner, Armstrong Teasdale LLP; Former Assistant District Attorney, Philadelphia; Philadelphia, PA |
Ali Lyons
Senior Director, Ethics & Compliance, Aegerion Pharmaceuticals, a Novelion Therapeutics Company, Former Operations Lead, Ethics and Compliance, Eli Lilly and Company, Cambridge, MA |
Jill Fallows Macaluso, JD, RN
Corporate Vice President, Chief Ethics & Compliance Officer, Novo Nordisk Inc., Princeton, NJ
|
Susan Markel
Managing Director, AlixPartners, Former Chief Accountant, Division of Enforcement, US Securities and Exchange Commission, Washington DC |
Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim, Ridgefield, C |
Heather McCollum, JD, MHA, CCEP-I
Director Compliance, Shionogi Inc., Florham Park, NJ
|
William A. McConagha, JD
Partner, Sidley Austin, LLP, Former Health Policy Advisor, Health, Education, Labor and Pensions Committee, US Senate, Former Assistant Commissioner, US Food and Drug Administration, Washington, DC |
Jenny McVey, PhD
Compliance Risk & Mitigation, Novo Nordisk, Inc., Former Compliance Officer, Hands International, Princeton, NJ |
Gregory S. Moss, JD
Senior Vice President, Deputy General Counsel, Kadmon Corporation, LLC, New York, NY
|
Kamleh J. Nicola, LLB
Partner, Baker & McKenzie LLP, Toronto, Canada |
Katherine Norris, MPA
Director, Corporate Compliance & Risk Management, Berkeley Research Group LLC, Washington, DC |
Dan O'Connor
Senior Vice President, PharmaCertify, a Division of NXLevel Solutions, New York, NY
|
Michael O'Connor
Vice President of Compliance Technology, Porzio Life Sciences, LLC, Former Global Head Compliance and Ethics Operations, Alexion, Former Executive Director, Global Head, IS Business Consulting, Boehringer Ingelheim, New York, NY |
Amy Pawloski, CPA, PMP, CCEP
Compliance Officer-Operations, Endo Pharmaceuticals; Former Global Lead, Compliance Risk Mitigation and Monitoring Strategy, Bristol-Myers Squibb; Philadelphia, PA |
Erica Powers
Director, Compliance Operations, Sage Therapeutics, Former Director Corporate Compliance, Vertex, Cambridge, MA
|
Arjun Rajaratnam, JD, MS
Chief Compliance Officer, Smith & Nephew; Former Compliance Officer, US Pharmaceuticals, GlaxoSmithKline; Former Member, PCF Executive Committee; Raleigh, NC |
Sunitha Ramamurthy, JD
Head of Compliance, Loxo Oncology, wholly owned subsidiary of Eli Lilly; Former Executive Director, Office of Ethics and Compliance, Boehringer Ingelheim Pharmaceuticals; Stamford, CT |
Kristin Rand, JD, MA
Vice President and Compliance Officer, Seattle Genetics, Former Compliance Director, Policy, Ethics, Training & Communication, Genentech, New York, NY
|
Marc Stephen Raspanti, JD
Partner, Pietragallo Gordon Alfano Bosick & Raspanti, LLP, Co-chair, White Collar Committee Qui Tam Subcommittee, ABA Criminal Justice Section, Philadelphia, PA |
Kelly N. "Nikki" Reeves, MPA, JD
Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding LLP, Washington, DC |
Lesley C. Reynolds, JD
Partner, Life Sciences Health Industry Group, Reed Smith, Washington, DC
|
Chapman Richardson
Global Head, Data Consumerization, Sanofi; Former Global Head Next Generation Digital, Novartis; Bridgewater, NJ |
Angela Rodin, MBA
Principal, KPMG, Former Vice President, Global Head of Investigations and Monitoring, GlaxoSmithKline Pharma GmbH, Washington, DC |
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA
|
Amanda Masselam Strachan, JD
Assistant US Attorney and Chief, Health Care Fraud Unit, US Attorney's Office, District of Massachusetts, US Attorney's Office, US Department of Justice, Boston, MA |
Jack Tanselle, MBA
Managing Director, Deloitte & Touche LLP, Indianapolis, IN |
Ann-Marie Tejcek, MA
Senior Director North American Ethics & Compliance Officer, Eli Lilly and Company, Indianapolis, IN
|
Manny Tzavlakis
Managing Partner, Helio Health, Morristown, NJ |
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS; Washington, DC |
Beth Weinman, JD
Counsel at Ropes & Gray LLP; Former Associate Chief Counsel, FDA; Washington, DC
|
Elizabeth Weiss, JD
Assistant General Counsel; Chief Compliance Counsel, Pfizer, Peapack, NJ |
Caroline West, JD
Global Chief Compliance Officer, Olympus Corporation, Former Sr. VP , Chief Compliance and Risk Officer, Shire, Former VP Global Legal Compliance, Aventis, Philadelphia, PA |
Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC; Editor, Life Science Compliance Update; Senior Fellow & Adjunct Professor, Life Sciences Compliance at Mitchell Hamline School of Law, West Chester, PA
|
Jonathan Wilkenfeld, MBA
Partner, Potomac River Partners, Washington, DC |
Catherine Williams, JD
Director - Privacy Office, Novo Nordisk, Former Assistant General Counsel, Privacy & K-12, Corrections & Leisure, Aramark, Plainsboro, NJ
|
Susan Williamson, MBA, CPA
Senior Vice President & Chief Compliance Officer, Endo Pharmaceuticals, Former Senior Manager, WBB Finance, Operational Risk Management, Pfizer, Philadelphia, PA |
Susan Winkler, JD
Partner, Pierce Bainbridge Beck Price & Hecht LLP, Former Assistant US Attorney and Head, Health Care Fraud Unit, US Attorney's Office for the District of Massachusetts, Boston, MA
|
|
|
2019-2020 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
TWENTIETH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Policy & Medicine Compliance Update
November 6 - 8, 2019
Mandarin Oriental, Washington, DC
www.PharmaCongress.com
|
|
FOURTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partner: Policy & Medicine Compliance Update
April 20 - 22, 2020
Sheraton Munich Arabellapark Hotel
Munich, Germany
www.International PharmaCongress.com
|
|
|
|
|
|
SPONSORED BY
|
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 70+ distinguished researched-based pharmaceutical manufacturers and biotech companies. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effect corporate compliance programs.
|
|
CO CHAIRS
|
Sujata T. Dayal, JD
Vice President, Health Care Compliance & Privacy, Pharmaceuticals Group, Johnson & Johnson, Titusville, NJ (PCF Secretary)
Jeffrey Kawalek, MBA
Deputy Chief Compliance Officer, Jazz Pharmaceuticals, Inc., Philadelphia, PA (PCF Chair)
Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD (PCF Treasurer)
Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi US, Bridgewater, NJ (PCF Co-Chair)
Donna White, CCEP
Vice President, Contracts & Compliance, Chiesi, USA, Cary, NC (PCF Co-Chair)
Joe Zimmerman
Vice President and Chief Compliance Officer US, Ferring Pharmaceuticals, Parsippany, NJ (PCF Co-Chair)
|
|
REMEMBER THE FIRST PHARMA CONGRESS
|
|
|
GRANTORS:
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
MEDIA PARTNERS:
|
|
|
TUITION SCHOLARSHIPS
|
The Pharma Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of local, state and federal government, consumer advocate organizations, safety net providers, academics, students and health services research organizations.
Click here for more information.
|
|
PARTICIPATION OPTIONS
|
|
TRADITIONAL ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
LIVE AND ARCHIVED WEBCAST PARTICIPATION
|
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.
The archived conference includes speaker videos and coordinated PowerPoint presentations.
Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office
|
|
WEBCAST INTERFACE SAMPLE
|
Click here for a sample stream
|
|
PHARMA CONGRESS IS
|
|
|
STAY CONNECTED
|
Tweet using #PharmaCongress
|
|
PAST GLOBAL PHARMA COMPLIANCE CONGRESSES
|
2007 - Brussels
2008 - Paris
2009 - Rome
2010 - Berlin
2011 - Istanbul
2011 - Singapore
2012 - Budapest
2012 - Shanghai
2012 - São Paulo
2013 - Madrid
2013 - Kuala Lumpur
2014 - Dubai
2014 - Mexico City
2014 - Shanghai
2015 - Manila
2016 - Warsaw
2017 - Lisbon
2018 - Vienna
|
|
|
|
|
